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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
COVID-19 Preparedness and Response 
Response strategies for COVID-19 epidemics in African settings: a mathematical 
modelling study 
Van Zandwoort, K, Jarvis, C.I. et al. | CMMID LSHTM | 19 April 2020 | Study not yet peer 
reviewed 
https://cmmid.github.io/topics/covid19/covid-response-strategies-africa.html 
Current evidence suggests large COVID-19 epidemics are expected in African settings. The health 
impact of COVID-19 may differ in African settings as compared to countries in Europe or China 
due to demographic, epidemiological, environmental and socio-economic factors. This study 
evaluated strategies to reduce SARS-CoV-2 burden in African countries to support decisions that 
balance minimising mortality, protecting health services and safeguarding livelihoods. 
Strategies combining self-isolation, moderate physical distancing and shielding likely 
most effective COVID-19 response for African countries 
LSHTM | 21 April 2020 | News 
https://www.lshtm.ac.uk/newsevents/news/2020/strategies-combining-self-isolation-moderate-
physical-distancing-and-shielding 
Can a virus undermine human rights? 
Nay O | The Lancet Public Health | 20 April 2020 | Comment 
https://doi.org/10.1016/S2468-2667(20)30092-X 
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COVID-19: What Africa can learn from Africa – Community Care Centres 
Mokuwa, E.Y. et al | African Arguments | 17 April 2020 | Blog 
https://africanarguments.org/2020/04/17/covid-19-what-africa-can-learn-from-africa-community-
care-centres/ 
Answering the right questions for policymakers on COVID-19 
Graeden et al | The Lancet Global Health | 20 April 2020 | Correspondence 
https://doi.org/10.1016/S2214-109X(20)30191-1 
Basic descriptive epidemiology and national or global epidemic forecasting has been key to the 
pandemic response but leaves many questions unanswered at smaller scales or in applied 
settings. This Correspondence provides a Panel of key questions that frontline decision makers 
need to be able to address to respond and that can be addressed by currently available data or 
models. Although the questions are focused on the current needs in the USA, informed by what 
authors have been asked by the state and local response in the last two weeks, the same core 
challenges are being faced wherever there is an outbreak of COVID-19. 
Other healthcare commitments 
Tailoring malaria interventions in COVID-19 response 
WHO | 3 April 2020 | Report 
https://www.who.int/malaria/publications/atoz/tailoring-malaria-interventions-in-the-covid-19-
response/en/ 
WHO/UNICEF joint statement – maintaining routine immunization services vital during the 
COVID-19 pandemic 
WHO/UNICEF | 20 April 2020 | Joint WHO and UNICEF statement to mark European 
Immunization Week 2020 
http://www.euro.who.int/en/media-centre/events/events/2020/04/european-immunization-week-
2020/statements/whounicef-joint-statement-maintaining-routine-immunization-services-vital-
during-the-covid-19-pandemic 
Social Sciences 
Using graphics to cut through Covid’s complexity 
Marquette, H | Oxfam | 21 April 2020 | Blog 
https://oxfamblogs.org/fp2p/using-graphics-to-explain-covids-complexity/  
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Centring sexual and reproductive health and justice in the global COVID-19 response 
Stidham Hall et al. | The Lancet | 11 April 2020 | Comment 
https://doi.org/10.1016/S0140-6736(20)30801-1 
Research and Development 
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus 
viral-vectored vaccine: a dose-escalation, open-label, non-randomised uncontrolled phase 
1 trial 
Folegatti et al | The Lancet Infectious Diseases | 20 April 2020 | Article 
https://doi.org/10.1016/S1473-3099(20)30160-2 
There is currently no vaccine for human coronaviruses. This first-in-human clinical trial identified 
the ChAdOx1 MERS vaccine as safe and well tolerated at all tested doses. A single does was able 
to elicit both humoral and cellular responses against MERS-CoV. These results support 
progression into field phase 1b and 2 trials.  
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate 
for Middle East respiratory syndrome: an open-label, phase 1 trial 
Koch, T Dahlke, C et al | The Lancet Infectious Diseases | 20 April 2020 | Article 
https://doi.org/10.1016/S1473-3099(20)30248-6 
This phase 1 clinical trial identified the MVA-MERS-S vaccine as safe with homologous prime-
boost immunisation inducing both humoral and cellular responses against MERS-CoV. A dose-
effect relationship was observed for reactogenicity, but not for vaccine-induced immune 
responses. These results support progression into the next stage of trials. 
Economic impact 
The impact of COVID-19 on global poverty: Why sub-Saharan Africa might be the region 
hardest hit 
Mahler, DG et al | World Bank | 20 April 2020 | Blog 
https://blogs.worldbank.org/opendata/impact-covid-19-coronavirus-global-poverty-why-sub-
saharan-africa-might-be-region-hardest 
Online learning and events 
CGD conversations on COVID-19 and development: Mark Lowcock 
Tuesday 28 April 2020 1200 ET 
4 
https://www.cgdev.org/event/cgd-conversations-covid-19-and-development-mark-lowcock 
Under-Secretary General for Humanitarian Affairs and Emergency Relief Coordinator, Mark 
Lowcock, joins CDG President Masood Ahmed to discuss the impacts of the COVID-19 pandemic 
in fragile states and refugee communities. 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging 
respiratory viruses, including novel coronaviruses, and how to effectively respond to an outbreak. 
Intended for public health professionals, incident managers and personnel working for the UN, 
international organisations and NGOs. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 25 May 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
Unfacilitated access to this course remains. An updated version of this course will though be run 
from 25 May 2020. On this course you will learn what is known about the outbreak of COVID-19 
(week 1); what the practical implications for responding to COVID-19 are (week 2); and what we 
need to find out about COVID-19 (week 3). 
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
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COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
Tracking Dashboards 
Global WHO sitreps 
 WHO dashboard 
 Johns Hopkins University  
 FIND SARS-CoV-2 Test Tracker 
 WEF 
 Vaccine Centre LSHTM 
 Our World in Data 
 Global 5050 
 Humanitarian Data Exchange 
 Information is Beautiful 
 The Commons Project 
Regional  WHO Africa  
 African Arguments 
 European CDC 
Country Ghana 
 Indonesia 
 Sierra Leone 
 Singapore 
 UK 
 US 
Guidelines 
Global WHO 
 IASC 
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Regional Africa CDC 
Country Nigeria CDC 
 UK Government 
 UK ONS 
 NICE UK 
 US CDC 
Resource Hubs 
Multilaterals WHO 
 WHO risk communication 
 WHO Q&A 
 
WHO Global research 
COVID-19 Solidarity Response Fund 
 UN 
 UN Women 
 
UNOCHA 
UNHCR 
 UNICEF 
 UNESCO 
 UN WFP 
 World Bank 
Regional & Country 
 
 
Africa CDC 
African Union 
Academic journals The Lancet 
 NEJM 
 Elsevier 
 BMJ 
 Cell 
 PLoS 
 Cochrane reviews 
Global Health Institutes LSTM 
 LSHTM 
 Johns Hopkins University 
 ICL MRC Centre for Global Infectious Disease Analysis  
 ODI 
 Norwegian Institute of Public Health 
Ethics Rings HSG Resyst Reach Wellcome  
Clinical trials US NIH registered clinical trials  
Funding bodies UKRI 
 Wellcome 
Demographics WorldPop 
Global Impact Surveys Premise COVID-19 Global Impact Study 
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 GeoPoll: SSA 
TB Stop TB Partnership 
Disability IDA 
 Disability and inclusion 
 Coregroup IDDC  
SDGs Global Partnership for Sustainable Development Data  
Humanitarian Reliefweb 
 Humanitarian OpenStreetMap Team  
 SSHAP 
Narratives David Nabarro, WHO DG Special Envoy on COVID-19 
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